Legalize / European Union / Implementing Regulation

Commission Implementing Regulation (EU) 2025/544 of 25 March 2025 amending Implementing Regulation (EU) 2021/403 as regards model animal health certificates and model animal health/official certificates for the entry into the Union of consignments of certain categories of terrestrial animals and germinal products thereof

Type Implementing Regulation

Publication 2025-04-22

State In force

Text As published

Department European Commission, SANTE

Source EUR-Lex

articles 3

This is the act as published. Later amendments are not folded into the text below: each one is a separate act in this repository and an entry in this law's history.

Reform history JSON API


II. Animal health attestation I, the undersigned official veterinarian, hereby certify that: II.1. The equine animal described in Part I: II.1.1. is a registered horse as defined in Article 2, point (30), of Commission Delegated Regulation (EU) 2019/2035, not intended for slaughter in the framework of the eradication of a disease transmissible to equine animals; II.1.2. has not shown signs or symptoms of diseases listed for equine animals in Commission Implementing Regulation (EU) 2018/1882 during the clinical examination carried out on //_ (dd/mm/yyyy) ⁽¹⁾, this being within the last 48 hours or on the last working day prior to the date of its dispatch to the Union from the registered establishment; II.1.3. meets the requirements attested in points II.2 to II.3 of this animal health certificate; II.1.4. is accompanied by a written declaration, signed by the operator responsible for the animal, which is attached to this animal health certificate. II.2. Attestation on third country or territory, or zone thereof and in establishment of dispatch II.2.1. The equine animal is dispatched from … (insert name of the third country or territory, or zone thereof), a third country or territory, or zone thereof which on the date of issuing this animal health certificate has the code _- ⁽²⁾ and is assigned to Sanitary Group … ⁽²⁾. II.2.2. The equine animal described in Part I comes from a third country or territory, or zone thereof in which there has been no clinical, serological (in unvaccinated equine animals) or epidemiological evidence of African horse sickness during the last 24 months prior to the date of dispatch of the animal to the Union and there has been no vaccination against African horse sickness during the last12 months prior to the date of its dispatch to the Union. II.2.3. The equine animal described in Part I comes from an establishment situated in a third country or territory, or zone thereof in which ⁽³⁾ either [infection with Burkholderia mallei (glanders) has not been reported during the last 36 months prior to the date of dispatch of the animal to the Union.] ⁽³⁾ or [a surveillance programme for infection with Burkholderia mallei (glanders) recognised by the Union ⁽¹⁾has been carried out during the last 36 months prior to the date of its dispatch to the Union, and ⁽³⁾ either [infection with Burkholderia mallei (glanders) has not been reported in the establishment of dispatch during the last 36 months prior to the date of dispatch of the animal to the Union.]] ⁽³⁾ or [infection with Burkholderia mallei (glanders) has been reported in the establishment during the last 36 months prior to the date of dispatch of the animal and following the last outbreak, the establishment has remained under movement restrictions ⁽³⁾ either [until the date on which the remaining equine animals in the establishment have been subjected to a complement fixation test for infection with Burkholderia mallei (glanders) ⁽⁴⁾, carried out, with negative results at a serum dilution of 1 in 5, on samples taken at least 6 months after the date on which the infected animals have been killed and destroyed.]]] ⁽³⁾ or [for at least 30 days after the date on which the last equine animal on the establishment was killed and destroyed, and the establishment was cleaned and disinfected.]]] II.2.4. The equine animal described in Part I comes from an establishment situated in a third country or territory, or zone thereof in which ⁽³⁾ either [surra has not been reported during the last 24 months prior to the date of dispatch of the animal to the Union.] ⁽³⁾ or [a surveillance programme for surra recognised by the Union ⁽¹⁾has been carried out during the last 24 months prior to the date of dispatch of the animal to the Union, and ⁽³⁾ either [surra has not been reported in the establishment during the last 24 months prior to the date of dispatch of the animal to the Union.]] ⁽³⁾ or [surra has been reported in the establishment during the last 24 months prior to the date of dispatch of the animal to the Union, and following the last outbreak, the establishment has remained under movement restrictions ⁽³⁾ either [until the date on which the remaining animals in the establishment have been subjected to an enzyme-linked immunosorbent assay (ELISA) for trypanosomosis or card agglutination test for trypanosomosis (CATT) at a serum dilution of 1 in 4 ⁽⁴⁾ carried out, with negative results, on samples taken at least 6 months after the date on which the last infected animal has been removed from the establishment.]]] ⁽³⁾ or [for at least 30 days after the date on which the last animal of listed species on the establishment was either killed and destroyed or slaughtered, and the establishment was cleaned and disinfected.]]] II.2.5. The equine animal described in Part I comes from an establishment situated in a third country or territory, or zone thereof in which ⁽³⁾ either [dourine has not been reported during the last 24 months prior to the date of dispatch of the animal to the Union.] ⁽³⁾ or [a surveillance programme for dourine recognised by the Union ⁽¹⁾has been carried out during the last 24 months prior to the date of dispatch of the animal to the Union, and ⁽³⁾ either [dourine has not been reported in the establishment during the last 24 months prior to the date of dispatch of the animal to the Union.]] ⁽³⁾ or [dourine has been reported in the establishment during the last 24 months prior to the date of dispatch of the animal to the Union, and following the last outbreak, the establishment has remained under movement restrictions ⁽³⁾ either [until the date on which the remaining equine animals in the establishment, except castrated male equine animals, have been subjected to a complement fixation test for dourine, carried out with negative results at a serum dilution of 1 in 5 ⁽⁴⁾ on samples taken at least 6 months after the date the infected animals have been killed and destroyed or slaughtered, or the date on which the infected entire male equine animals have been castrated.]]] ⁽³⁾ or [for at least 30 days after the date on which the last equine animal on the establishment was either killed and destroyed or slaughtered, and the establishment was cleaned and disinfected.]]] II.2.6. The equine animal described in Part I has not been vaccinated against Venezuelan equine encephalomyelitis during the last 60 days prior to the date of its dispatch to the Union, and ⁽³⁾ either [it comes from an establishment situated in a third country or territory in which Venezuelan equine encephalomyelitis has not been reported during the last 24 months prior to the date of its dispatch to the Union.] ⁽³⁾ or [it comes from an establishment in which Venezuelan equine encephalomyelitis has not been reported during the last 6 months prior to the date of its dispatch to the Union and during the last 21 days prior to the date of dispatch of the animal described in Part I to the Union, all equine animals in the establishment have remained clinically healthy, and ⁽³⁾ either [the equine animal described in Part I has been kept protected from attacks by insect vectors in a vector-protected establishment, in which any equine animal that showed a rise in daily taken body temperature has been subjected with negative result to a virus isolation test for Venezuelan equine encephalomyelitis ⁽⁴⁾; and the equine animal described in Part I ⁽³⁾ either [was vaccinated against Venezuelan equine encephalomyelitis with a complete primary course and revaccinated according to manufacturer's recommendations not less than 60 days and not more than 12 months prior to the date of dispatch of the animal to the Union.]]] ⁽³⁾ or [was subjected to a haemagglutination inhibition test for Venezuelan equine encephalomyelitis ⁽⁴⁾, carried out, with negative result, on a sample taken not less than 14 days after the date of commencement of isolation in the vector-protected establishment.]]] ⁽³⁾ or [the body temperature of the equine animal described in Part I has been taken daily, either without a rise or the animal has been subjected to a virus isolation test for Venezuelan equine encephalomyelitis with negative result, and the equine animal described in Part I has been subjected to: (a) a haemagglutination inhibition test for Venezuelan equine encephalomyelitis ⁽⁴⁾, without an increase in antibody titre, carried out on paired samples taken on two occasions with an interval of 21 days, the second of which was taken during the last 10 days prior to the date of its dispatch to the Union, and (b) a reverse transcription-polymerase chain reaction (RT-PCR) for the detection of Venezuelan equine encephalomyelitis virus genome ⁽⁴⁾, with negative result, carried out on a sample taken within the last 48 hours prior to its dispatch to the Union, and (c) protection from vector attacks during the period after the date of sampling until loading for dispatch to the Union, by combined use of approved insect repellents and insecticides on the animal and disinsectization of the stable and the means in which it is transported.]] II.2.7. The equine animal described in Part I comes from an establishment in which ⁽³⁾ either [equine infectious anaemia has not been reported during the last 12 months prior to the date of dispatch of the animal to the Union.] ⁽³⁾ or [equine infectious anaemia has been reported during the last 12 months prior to the date of dispatch of the animal to the Union and following the last outbreak, the establishment has remained under movement restrictions ⁽³⁾ either [until the date on which the remaining equine animals in the establishment have been subjected to an agar gel immuno-diffusion test (AGID or Coggins test) or ELISA ⁽⁴⁾ for equine infectious anaemia carried out, with negative results, on samples taken on two occasions with a minimum interval of 90 days following the date on which the infected animals have been killed and destroyed or slaughtered, and the establishment was cleaned and disinfected.]] ⁽³⁾ or [for at least 30 days after the date on which the last equine animal on the establishment was either killed and destroyed or slaughtered, and the establishment was cleaned and disinfected.]] II.2.8. The equine animal described in Part I comes from an establishment in which: II.2.8.1. infection with rabies virus in kept terrestrial animals has not been reported during the last 30 days prior to the date of dispatch of the animal to the Union; II.2.8.2. anthrax in ungulates has not been reported during the last 15 days prior to the date of dispatch of the animal to the Union. II.2.9. To the best of my knowledge and as declared by the operator, the equine animal described in Part I has not been in contact with kept animals of listed species which did not comply with the requirements referred to in points II.2.2 to II.2.8.1 during the last 30 days prior to the date of dispatch of the animal to the Union, and with the requirement referred to in point II.2.8.2 during the last 15 days prior to the date of dispatch of the animal to the Union. II.3. Attestation of residence and isolation prior to dispatch to the Union II.3.1. The equine animal described in Part I was introduced into the third country or territory, or zone thereof of dispatch to the European Union on //_ (dd/mm/yyyy) ⁽³⁾ either [directly from the Member State of the European Union … (insert name of a Member State) for the participation in ⁽³⁾ either [The Dubai Racing World-Cup;]] ⁽³⁾ or [The Melbourne Cup;]] ⁽³⁾ or [The Bahrain Turf Series;]] ⁽³⁾ or [The Hong Kong International Races;]] ⁽³⁾ or [The Japan Cup;]] ⁽³⁾ or [The Saudi Cup;]] ⁽³⁾ or [International Group/Grade meetings in the United Arab Emirates ⁽³⁾, Australia ⁽³⁾, Bahrain ⁽³⁾, Canada ⁽³⁾, Hong Kong ⁽³⁾, Japan ⁽³⁾, Qatar ⁽³⁾, Singapore ⁽³⁾, the United States ⁽³⁾.]] ⁽³⁾ or [from the United Arab Emirates ⁽³⁾, Australia ⁽³⁾, Bahrain ⁽³⁾, Canada ⁽³⁾, Hong Kong ⁽³⁾, Japan ⁽³⁾, Qatar ⁽³⁾, Singapore ⁽³⁾ or the United States ⁽³⁾ for the participation in International Group/Grade meetings in the third country or territory of dispatch, or from Australia ⁽³⁾ for the participation in the Melbourne Cup.] II.3.2. As far as can be ascertained and based on the declaration of the operator of the horse accompanying this animal health certificate, the equine animal was: (a) not continuously outside the European Union for more than 90 days, including the date of scheduled return in accordance with this animal health certificate; (b) not outside the third country or territory of dispatch to the European Union or in case of International Group/Grade meetings or the Melbourne Cup outside the United Arab Emirates, Australia, Bahrain, Canada, Hong Kong, Japan, Qatar, Singapore or the United States; (c) resident in the establishments under official veterinary supervision, accommodated in separated stables without coming into contact with equine animals of lower health status except during racing. II.3.3. The equine animal entered the third country or territory of dispatch to the European Union under animal health conditions at least as strict as those laid down in this animal health certificate. Notes: In accordance with the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union and the European Atomic Energy Community, and in particular Article 5(4) of the Windsor Framework (see Joint Declaration No 1/2023 of the Union and the United Kingdom in the Joint Committee established by the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union and the European Atomic Energy Community of 24 March 2023, OJ L 102, 17.4.2023, p. 87) in conjunction with Annex 2 to that Framework, references to the Union in this animal health certificate include the United Kingdom in respect of Northern Ireland. This animal health certificate shall be completed in accordance with the notes for the completion of certificates provided for in Chapter 4 of Annex I to Commission Implementing Regulation (EU) 2020/2235. Part I: Box reference I.6 : Provide the information on the operator responsible for the animal. Box reference I.8 : Provide the code of the third country or territory, or zone thereof of dispatch to the Union as appearing in column 2 of the table in Part 1 of Annex IV to Commission Implementing Regulation (EU) 2021/404. Box reference I.27 : “Identification system”: The animal shall be individually identified with one of the means of identification defined in point (a), (c), (e), or (g) of Annex III to Delegated Regulation (EU) 2019/2035, or be identified by an alternative method in accordance with Article 62 of that Regulation (for example, brand) provided it is recorded in its identification document (passport). Specify the identification system and the anatomic place used on the animal. The number of the accompanying passport or the Unique Code, if no passport number is available, shall be stated and the name of the competent authority which validated it. “Age”: Date of birth (dd/mm/yyyy). “Sex”: M = male, F = female, C = castrated. Part II: ⁽¹⁾ The animal health certificate shall be issued within the last 10 days prior to the date of arrival of the consignment at the border control post; in the case of transport by sea, the period may be extended by an additional period corresponding to the duration of the journey by sea. The entry into the Union shall not be allowed when the animal was loaded either prior to the date of authorisation for the entry into the Union from the respective third country or territory, or zone thereof referred to in point II.2.1, or during a period where restrictive measures have been adopted by the Union against the entry into the Union of equine animals from that third country or territory, or zone thereof. Check against columns 8 and 9 of the table in Part 1 of Annex IV to Implementing Regulation (EU) 2021/404. ⁽²⁾ Code of the third country or territory, or zone thereof and the Sanitary Group as appearing respectively in columns 2 and 3 of the table in Part 1 of Annex IV to Implementing Regulation (EU) 2021/404. ⁽³⁾ Delete if not applicable. ⁽⁴⁾ Tests for glanders, surra, dourine, equine infectious anaemia and Venezuelan equine encephalomyelitis described by the European Union Reference Laboratory for Equine Diseases other than African horse sickness: https://sitesv2.anses.fr/en/minisite/equine-diseases/sop. Official veterinarian Name (in capital letters) Date Qualification and title Stamp Signature Declaration by the operator responsible for the re-entry into the Union after temporary export of a registered horse for racing Identification of the animal ⁽¹⁾ Species (scientific name) *Equus caballus* Identification system … Identification number … Age … Sex … I, the undersigned operator of the registered horse described above, hereby declare, that: (a) the registered horse ⁽²⁾ either [was temporarily exported from the Union to the third country or territory, or zone thereof of dispatch to the Union on //_ (dd/mm/yyyy) less than 90 days prior to the date of issue of this declaration;] ⁽²⁾ or [entered the third country or territory, or zone thereof of dispatch to the Union on //____ (dd/mm/yyyy) from … (insert name of third country or territory, or zone thereof from where the registered horse entered the third country or territory, or zone thereof of dispatch to the Union);] (b) the registered horse has been temporarily exported from the Union to take part in ⁽²⁾ either [The Dubai Racing World-Cup;] ⁽²⁾ or [The Bahrain Turf Series;] ⁽²⁾ or [The Melbourne Cup;] ⁽²⁾ or [The Hong Kong International Races;] ⁽²⁾ or [The Japan Cup;] ⁽²⁾ or [The Saudi Cup;] ⁽²⁾ or [International Group/Grade meetings in the United Arab Emirates ⁽²⁾, Australia ⁽²⁾, Bahrain ⁽²⁾, Canada ⁽²⁾, Hong Kong ⁽²⁾, Japan ⁽²⁾, Qatar ⁽²⁾, Singapore ⁽²⁾ or the United States ⁽²⁾; or the Melbourne Cup in Australia ⁽²⁾;] (c) during the last 15 days prior to the date of dispatch to the Union the registered horse has not been in contact with animals suffering from infectious or contagious diseases transmissible to equine animals; (d) the transportation will be effected in such a way that health and welfare of the registered horse can be protected effectively at all stages of the journey; (e) the conditions for residence and pre-export isolation as applicable in accordance with point II.3 of the accompanying animal health certificate for the third country or territory, or zone thereof of dispatch to the Union are fulfilled. Name and address of the operator … Date … (dd/mm/yyyy) … (Signature) ⁽¹⁾ Identification system: The animal shall be individually identified with one of the means of identification defined in point (a), (c), (e), or (g) of Annex III to Commission Delegated Regulation (EU) 2019/2035, or be identified by an alternative method in accordance with Article 62 of that Delegated Regulation provided it is recorded in its identification document (passport). Specify the identification system (such as tattoo, brand, transponder etc.) and the anatomic place used on the animal. The number of the accompanying passport or the Unique Code, if no passport number is available, shall be stated and the name of the competent authority which validated the passport. Age: Date of birth (dd/mm/yyyy). Sex (M = male, F = female, C = castrated). ⁽²⁾ Delete if not applicable.

II. Animal health attestation I, the undersigned official veterinarian, hereby certify that: II.1. The equine animal described in Part I: II.1.1. is a registered horse as defined in Article 2, point (30), of Commission Delegated Regulation (EU) 2019/2035, not intended for slaughter in the framework of the eradication of a disease transmissible to equine animals; II.1.2. has not shown signs or symptoms of diseases listed for equine animals in Commission Implementing Regulation (EU) 2018/1882 during the clinical examination carried out on //_ (dd/mm/yyyy) ⁽¹⁾, this being within the last 48 hours or on the last working day prior to the date of its dispatch to the Union from the registered establishment; II.1.3. meets the requirements attested in points II.2 to II.3 of this animal health certificate; II.1.4. is accompanied by a written declaration, signed by the operator responsible for the animal, which is attached to this animal health certificate. II.2. Attestation on third country or territory, or zone thereof and in establishment of dispatch II.2.1. The equine animal is dispatched from … (insert name of the third country or territory, or zone thereof), a third country or territory, or zone thereof which on the date of issuing this animal health certificate has the code _- ⁽²⁾ and is assigned to Sanitary Group … ⁽²⁾. II.2.2. The equine animal described in Part I comes from a third country or territory, or zone thereof in which there has been no clinical, serological (in unvaccinated equine animals) or epidemiological evidence of African horse sickness during the last 24 months prior to the date of dispatch of the animal to the Union and there has been no vaccination against African horse sickness during the last12 months prior to the date of its dispatch to the Union. II.2.3. The equine animal described in Part I comes from an establishment situated in a third country or territory, or zone thereof in which ⁽³⁾ either [infection with Burkholderia mallei (glanders) has not been reported during the last 36 months prior to the date of dispatch of the animal to the Union.] ⁽³⁾ or [a surveillance programme for infection with Burkholderia mallei (glanders) recognised by the Union ⁽¹⁾has been carried out during the last 36 months prior to the date of its dispatch to the Union, and ⁽³⁾ either [infection with Burkholderia mallei (glanders) has not been reported in the establishment of dispatch during the last 36 months prior to the date of dispatch of the animal to the Union.]] ⁽³⁾ or [infection with Burkholderia mallei (glanders) has been reported in the establishment during the last 36 months prior to the date of dispatch of the animal and following the last outbreak, the establishment has remained under movement restrictions ⁽³⁾ either [until the date on which the remaining equine animals in the establishment have been subjected to a complement fixation test for infection with Burkholderia mallei (glanders) ⁽⁴⁾, carried out, with negative results at a serum dilution of 1 in 5, on samples taken at least 6 months after the date on which the infected animals have been killed and destroyed.]]] ⁽³⁾ or [for at least 30 days after the date on which the last equine animal on the establishment was killed and destroyed, and the establishment was cleaned and disinfected.]]] II.2.4. The equine animal described in Part I comes from an establishment situated in a third country or territory, or zone thereof in which ⁽³⁾ either [surra has not been reported during the last 24 months prior to the date of dispatch of the animal to the Union.] ⁽³⁾ or [a surveillance programme for surra recognised by the Union ⁽¹⁾has been carried out during the last 24 months prior to the date of dispatch of the animal to the Union, and ⁽³⁾ either [surra has not been reported in the establishment during the last 24 months prior to the date of dispatch of the animal to the Union.]] ⁽³⁾ or [surra has been reported in the establishment during the last 24 months prior to the date of dispatch of the animal to the Union, and following the last outbreak, the establishment has remained under movement restrictions ⁽³⁾ either [until the date on which the remaining animals in the establishment have been subjected to an enzyme-linked immunosorbent assay (ELISA) for trypanosomosis or card agglutination test for trypanosomosis (CATT) at a serum dilution of 1 in 4 ⁽⁴⁾ carried out, with negative results, on samples taken at least 6 months after the date on which the last infected animal has been removed from the establishment.]]] ⁽³⁾ or [for at least 30 days after the date on which the last animal of listed species on the establishment was either killed and destroyed or slaughtered, and the establishment was cleaned and disinfected.]]] II.2.5. The equine animal described in Part I comes from an establishment situated in a third country or territory, or zone thereof in which ⁽³⁾ either [dourine has not been reported during the last 24 months prior to the date of dispatch of the animal to the Union.] ⁽³⁾ or [a surveillance programme for dourine recognised by the Union ⁽¹⁾has been carried out during the last 24 months prior to the date of dispatch of the animal to the Union, and ⁽³⁾ either [dourine has not been reported in the establishment during the last 24 months prior to the date of dispatch of the animal to the Union.]] ⁽³⁾ or [dourine has been reported in the establishment during the last 24 months prior to the date of dispatch of the animal to the Union, and following the last outbreak, the establishment has remained under movement restrictions ⁽³⁾ either [until the date on which the remaining equine animals in the establishment, except castrated male equine animals, have been subjected to a complement fixation test for dourine, carried out with negative results at a serum dilution of 1 in 5 ⁽⁴⁾ on samples taken at least 6 months after the date the infected animals have been killed and destroyed or slaughtered, or the date on which the infected entire male equine animals have been castrated.]]] ⁽³⁾ or [for at least 30 days after the date on which the last equine animal on the establishment was either killed and destroyed or slaughtered, and the establishment was cleaned and disinfected.]]] II.2.6. The equine animal described in Part I has not been vaccinated against Venezuelan equine encephalomyelitis during the last 60 days prior to the date of its dispatch to the Union, and ⁽³⁾ either [it comes from an establishment situated in a third country or territory in which Venezuelan equine encephalomyelitis has not been reported during the last 24 months prior to the date of its dispatch to the Union.] ⁽³⁾ or [it comes from an establishment in which Venezuelan equine encephalomyelitis has not been reported during the last 6 months prior to the date of its dispatch to the Union and during the last 21 days prior to the date of dispatch of the animal described in Part I to the Union, all equine animals in the establishment have remained clinically healthy, and ⁽³⁾ either [the equine animal described in Part I has been kept protected from attacks by insect vectors in a vector-protected establishment, in which any equine animal that showed a rise in daily taken body temperature has been subjected with negative result to a virus isolation test for Venezuelan equine encephalomyelitis ⁽⁴⁾; and the equine animal described in Part I ⁽³⁾ either [was vaccinated against Venezuelan equine encephalomyelitis with a complete primary course and revaccinated according to manufacturer's recommendations not less than 60 days and not more than 12 months prior to the date of dispatch of the animal to the Union.]]] ⁽³⁾ or [was subjected to a haemagglutination inhibition test for Venezuelan equine encephalomyelitis ⁽⁴⁾, carried out, with negative result, on a sample taken not less than 14 days after the date of commencement of isolation in the vector-protected establishment.]]] ⁽³⁾ or [the body temperature of the equine animal described in Part I has been taken daily, either without a rise or the animal has been subjected to a virus isolation test for Venezuelan equine encephalomyelitis with negative result, and the equine animal described in Part I has been subjected to: (a) a haemagglutination inhibition test for Venezuelan equine encephalomyelitis ⁽⁴⁾, without an increase in antibody titre, carried out on paired samples taken on two occasions with an interval of 21 days, the second of which was taken during the last 10 days prior to the date of its dispatch to the Union, and (b) a reverse transcription-polymerase chain reaction (RT-PCR) for the detection of Venezuelan equine encephalomyelitis virus genome ⁽⁴⁾, with negative result, carried out on a sample taken within the last 48 hours prior to its dispatch to the Union, and (c) protection from vector attacks during the period after the date of sampling until loading for dispatch to the Union, by combined use of approved insect repellents and insecticides on the animal and disinsectization of the stable and the means in which it is transported.]] II.2.7. The equine animal described in Part I comes from an establishment in which ⁽³⁾ either [equine infectious anaemia has not been reported during the last 12 months prior to the date of dispatch of the animal to the Union.] ⁽³⁾ or [equine infectious anaemia has been reported during the last 12 months prior to the date of dispatch of the animal to the Union and following the last outbreak, the establishment has remained under movement restrictions ⁽³⁾ either [until the date on which the remaining equine animals in the establishment have been subjected to an agar gel immuno-diffusion test (AGID or Coggins test) or ELISA ⁽⁴⁾ for equine infectious anaemia carried out, with negative results, on samples taken on two occasions with a minimum interval of 90 days following the date on which the infected animals have been killed and destroyed or slaughtered, and the establishment was cleaned and disinfected.]] ⁽³⁾ or [for at least 30 days after the date on which the last equine animal on the establishment was either killed and destroyed or slaughtered, and the establishment was cleaned and disinfected.]] II.2.8. The equine animal described in Part I comes from an establishment in which: II.2.8.1. infection with rabies virus in kept terrestrial animals has not been reported during the last 30 days prior to the date of dispatch of the animal to the Union; II.2.8.2. anthrax in ungulates has not been reported during the last 15 days prior to the date of dispatch of the animal to the Union. II.2.9. To the best of my knowledge and as declared by the operator, the equine animal described in Part I has not been in contact with kept animals of listed species which did not comply with the requirements referred to in points II.2.2 to II.2.8.1 during the last 30 days prior to the date of dispatch of the animal to the Union, and with the requirement referred to in point II.2.8.2 during the last 15 days prior to the date of dispatch of the animal to the Union. II.3. Attestation of residence and isolation prior to dispatch to the Union II.3.1. The equine animal described in Part I was introduced into the third country or territory, or zone thereof of dispatch to the European Union on //_ (dd/mm/yyyy) ⁽³⁾ either [directly from the Member State of the European Union … (insert name of a Member State) for the participation in ⁽³⁾ either [The Dubai Racing World-Cup;]] ⁽³⁾ or [The Melbourne Cup;]] ⁽³⁾ or [The Bahrain Turf Series;]] ⁽³⁾ or [The Hong Kong International Races;]] ⁽³⁾ or [The Japan Cup;]] ⁽³⁾ or [The Saudi Cup;]] ⁽³⁾ or [International Group/Grade meetings in the United Arab Emirates ⁽³⁾, Australia ⁽³⁾, Bahrain ⁽³⁾, Canada ⁽³⁾, Hong Kong ⁽³⁾, Japan ⁽³⁾, Qatar ⁽³⁾, Singapore ⁽³⁾, the United States ⁽³⁾.]] ⁽³⁾ or [from the United Arab Emirates ⁽³⁾, Australia ⁽³⁾, Bahrain ⁽³⁾, Canada ⁽³⁾, Hong Kong ⁽³⁾, Japan ⁽³⁾, Qatar ⁽³⁾, Singapore ⁽³⁾ or the United States ⁽³⁾ for the participation in International Group/Grade meetings in the third country or territory of dispatch, or from Australia ⁽³⁾ for the participation in the Melbourne Cup.] II.3.2. As far as can be ascertained and based on the declaration of the operator of the horse accompanying this animal health certificate, the equine animal was: (a) not continuously outside the European Union for more than 90 days, including the date of scheduled return in accordance with this animal health certificate; (b) not outside the third country or territory of dispatch to the European Union or in case of International Group/Grade meetings or the Melbourne Cup outside the United Arab Emirates, Australia, Bahrain, Canada, Hong Kong, Japan, Qatar, Singapore or the United States; (c) resident in the establishments under official veterinary supervision, accommodated in separated stables without coming into contact with equine animals of lower health status except during racing. II.3.3. The equine animal entered the third country or territory of dispatch to the European Union under animal health conditions at least as strict as those laid down in this animal health certificate. Notes: In accordance with the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union and the European Atomic Energy Community, and in particular Article 5(4) of the Windsor Framework (see Joint Declaration No 1/2023 of the Union and the United Kingdom in the Joint Committee established by the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union and the European Atomic Energy Community of 24 March 2023, OJ L 102, 17.4.2023, p. 87) in conjunction with Annex 2 to that Framework, references to the Union in this animal health certificate include the United Kingdom in respect of Northern Ireland. This animal health certificate shall be completed in accordance with the notes for the completion of certificates provided for in Chapter 4 of Annex I to Commission Implementing Regulation (EU) 2020/2235. Part I: Box reference I.6 : Provide the information on the operator responsible for the animal. Box reference I.8 : Provide the code of the third country or territory, or zone thereof of dispatch to the Union as appearing in column 2 of the table in Part 1 of Annex IV to Commission Implementing Regulation (EU) 2021/404. Box reference I.27 : “Identification system”: The animal shall be individually identified with one of the means of identification defined in point (a), (c), (e), or (g) of Annex III to Delegated Regulation (EU) 2019/2035, or be identified by an alternative method in accordance with Article 62 of that Regulation (for example, brand) provided it is recorded in its identification document (passport). Specify the identification system and the anatomic place used on the animal. The number of the accompanying passport or the Unique Code, if no passport number is available, shall be stated and the name of the competent authority which validated it. “Age”: Date of birth (dd/mm/yyyy). “Sex”: M = male, F = female, C = castrated. Part II: ⁽¹⁾ The animal health certificate shall be issued within the last 10 days prior to the date of arrival of the consignment at the border control post; in the case of transport by sea, the period may be extended by an additional period corresponding to the duration of the journey by sea. The entry into the Union shall not be allowed when the animal was loaded either prior to the date of authorisation for the entry into the Union from the respective third country or territory, or zone thereof referred to in point II.2.1, or during a period where restrictive measures have been adopted by the Union against the entry into the Union of equine animals from that third country or territory, or zone thereof. Check against columns 8 and 9 of the table in Part 1 of Annex IV to Implementing Regulation (EU) 2021/404. ⁽²⁾ Code of the third country or territory, or zone thereof and the Sanitary Group as appearing respectively in columns 2 and 3 of the table in Part 1 of Annex IV to Implementing Regulation (EU) 2021/404. ⁽³⁾ Delete if not applicable. ⁽⁴⁾ Tests for glanders, surra, dourine, equine infectious anaemia and Venezuelan equine encephalomyelitis described by the European Union Reference Laboratory for Equine Diseases other than African horse sickness: https://sitesv2.anses.fr/en/minisite/equine-diseases/sop. Official veterinarian Name (in capital letters) Date Qualification and title Stamp Signature Declaration by the operator responsible for the re-entry into the Union after temporary export of a registered horse for racing Identification of the animal ⁽¹⁾ Species (scientific name) Equus caballus Identification system … Identification number … Age … Sex … I, the undersigned operator of the registered horse described above, hereby declare, that: (a) the registered horse ⁽²⁾ either [was temporarily exported from the Union to the third country or territory, or zone thereof of dispatch to the Union on //_ (dd/mm/yyyy) less than 90 days prior to the date of issue of this declaration;] ⁽²⁾ or [entered the third country or territory, or zone thereof of dispatch to the Union on //____ (dd/mm/yyyy) from … (insert name of third country or territory, or zone thereof from where the registered horse entered the third country or territory, or zone thereof of dispatch to the Union);] (b) the registered horse has been temporarily exported from the Union to take part in ⁽²⁾ either [The Dubai Racing World-Cup;] ⁽²⁾ or [The Bahrain Turf Series;] ⁽²⁾ or [The Melbourne Cup;] ⁽²⁾ or [The Hong Kong International Races;] ⁽²⁾ or [The Japan Cup;] ⁽²⁾ or [The Saudi Cup;] ⁽²⁾ or [International Group/Grade meetings in the United Arab Emirates ⁽²⁾, Australia ⁽²⁾, Bahrain ⁽²⁾, Canada ⁽²⁾, Hong Kong ⁽²⁾, Japan ⁽²⁾, Qatar ⁽²⁾, Singapore ⁽²⁾ or the United States ⁽²⁾; or the Melbourne Cup in Australia ⁽²⁾;] (c) during the last 15 days prior to the date of dispatch to the Union the registered horse has not been in contact with animals suffering from infectious or contagious diseases transmissible to equine animals; (d) the transportation will be effected in such a way that health and welfare of the registered horse can be protected effectively at all stages of the journey; (e) the conditions for residence and pre-export isolation as applicable in accordance with point II.3 of the accompanying animal health certificate for the third country or territory, or zone thereof of dispatch to the Union are fulfilled. Name and address of the operator … Date … (dd/mm/yyyy) … (Signature) ⁽¹⁾ Identification system: The animal shall be individually identified with one of the means of identification defined in point (a), (c), (e), or (g) of Annex III to Commission Delegated Regulation (EU) 2019/2035, or be identified by an alternative method in accordance with Article 62 of that Delegated Regulation provided it is recorded in its identification document (passport). Specify the identification system (such as tattoo, brand, transponder etc.) and the anatomic place used on the animal. The number of the accompanying passport or the Unique Code, if no passport number is available, shall be stated and the name of the competent authority which validated the passport. Age: Date of birth (dd/mm/yyyy). Sex (M = male, F = female, C = castrated). ⁽²⁾ Delete if not applicable.

CHAPTER 18 (MODEL “CONFINED-RUM”)

Section 1

List of animals originating from and intended for a confined establishment covered by the model “CONFINED-RUM” set out in Section 2

Order	Family	Genera/species
Artiodactyla	Antilocapridae	Antilocapra ssp.
Artiodactyla	Bovidae	Addax ssp., Aepyceros ssp., Alcelaphus ssp., Ammodorcas ssp., Ammotragus ssp., Antidorcas ssp., Antilope ssp., Bison ssp., Bos ssp. (including Bibos, Novibos, Poephagus), Boselaphus ssp., Bubalus ssp. (including anoa), Budorcas ssp., Capra ssp., Cephalophus ssp., Connochaetes ssp., Damaliscus ssp. (including Beatragus), Dorcatragus ssp., Gazella ssp., Hemitragus ssp., Hippotragus ssp., Kobus ssp., Litocranius ssp., Madoqua ssp., Naemorhedus ssp. (including Nemorhaedus and Capricornis), Neotragus ssp., Oreamnos ssp., Oreotragus ssp., Oryx ssp., Ourebia ssp., Ovibos ssp., Ovis ssp., Patholops ssp., Pelea ssp., Procapra ssp., Pseudois ssp., Pseudoryx ssp., Raphicerus ssp., Redunca ssp., Rupicapra ssp., Saiga ssp., Sigmoceros-Alcelaphus ssp., Sylvicapra ssp., Syncerus ssp., Taurotragus ssp., Tetracerus ssp., Tragelaphus ssp. (including Boocerus).
Artiodactyla	Camelidae	Camelus ssp., Lama ssp., Vicugna ssp.
Artiodactyla	Cervidae	Alces ssp., Axis-Hyelaphus ssp., Blastocerus ssp., Capreolus ssp., Cervus-Rucervus ssp., Dama ssp., Elaphurus ssp., Hippocamelus ssp., Hydropotes ssp., Mazama ssp., Megamuntiacus ssp., Muntiacus ssp., Odocoileus ssp., Ozotoceros ssp., Pudu ssp., Rangifer ssp.
Artiodactyla	Giraffidae	Giraffa ssp., Okapia ssp.
Artiodactyla	Moschidae	Moschus ssp.
Artiodactyla	Tragulidae	Hyemoschus ssp., Tragulus-Moschiola ssp.

Section 2 MODEL ANIMAL HEALTH CERTIFICATE FOR THE ENTRY INTO THE UNION OF ANIMALS LISTED IN CHAPTER 18, SECTION 1, OF ANNEX II TO COMMISSION IMPLEMENTING REGULATION (EU) 2021/403 THAT ARE ORIGINATING FROM AND INTENDED FOR A CONFINED ESTABLISHMENT (MODEL “CONFINED-RUM”)

Part I: Description of consignment


COUNTRY	Animal health certificate to the EU

---	---
I.1	Consignor/Exporter
	Name
	Address
	Address
	Country
I.5	Consignee/Importer
	Name
	Address
	Country
I.7	Country of origin
I.8	Region of origin
I.11	Place of dispatch
	Name
	Address
	Country
I.13	Place of loading

---	---
I.15	Means of transport
	☐ Aircraft
	☐ Railway
	Identification
	Identification

---	---
I.18
I.19	Container number/Seal number
	Container No
I.20	Certified as or for


---	---
I.21


---	---
I.24

---	---
I.27	Description of consignment
CN code	Species

Part II: Certification


COUNTRY	COUNTRY	Certificate model CONFINED-RUM	Certificate model CONFINED-RUM	Certificate model CONFINED-RUM	Certificate model CONFINED-RUM
	II. Health information	II.a	Certificate reference	II.b	IMSOC reference


I, the undersigned official veterinarian, hereby certify, that the animals described in Part I: II.1.1. come from the zone with code - ⁽²⁾ which, at the date of issue of this animal health certificate is authorised for the entry into the Union of animals of the families Antilocapridae, Bovidae, Camelidae, Cervidae, Giraffidae, Moschidae, Tragulidae intended for confined establishments and listed in Part 1 of Annex III to Commission Implementing Regulation (EU) 2021/404; II.1.2. have remained continuously in the establishment of origin since birth, or for the last 6 months prior to the date of their dispatch to the Union; II.1.3. have not been in contact with animals of a lower health status for the last 30 days prior to the date of their dispatch to the Union, or since birth, if the animals are less than 30 days of age, and during their transport from the confined establishment of origin to the place of their dispatch to the Union; II.1.4. are not to be killed under a national programme for the eradication of diseases, including the listed diseases referred to in Annex I to Commission Delegated Regulation (EU) 2020/692 relevant for the species and emerging diseases; II.1.5. have been dispatched to the Union directly from the establishment of origin without passing through any other establishment; II.1.6. have not been unloaded in any place that does not comply with the requirements laid down in point II.1.11 since the date of dispatch from their establishment of origin until the date of their dispatch to the Union and during that period they have not been in contact with animals of a lower health status; II.1.7. are loaded for dispatch to the Union on //_ (dd/mm/yyyy) ⁽³⁾ in a means of transport which was cleaned and disinfected prior to loading with a disinfectant authorised by the competent authority in the third country or territory and constructed in such a way that: (a) animals cannot escape or fall out; (b) visual inspection of the space where animals are kept is possible; (c) the escape of animal excrements, litter or feed is prevented or minimized; II.1.8. have been subjected to a clinical inspection within the last 24 hours prior to the time of loading for their dispatch to the Union, carried out by an official veterinarian in the third country or territory of origin, or zone thereof, who did not detect signs indicative of the occurrence of diseases, including the listed diseases referred to in Annex I to Delegated Regulation (EU) 2020/692 relevant for the species and emerging diseases; II.1.9. have not been vaccinated against foot and mouth disease and infection with rinderpest virus; ⁽¹⁾ [II.1.10. have been vaccinated against ⁽¹⁾ [anthrax on //_ (dd/mm/yyyy) with the following vaccine(s): … … (name of vaccine(s) used);]] ⁽¹⁾ [rabies on //____ (dd/mm/yyyy) with the following vaccine(s): … … (name of vaccine(s) used);]] II.1.11. come from a confined establishment: II.1.11.1. which is approved by the competent authority in accordance with the conditions set out in Article 30 of Delegated Regulation (EU) 2020/692; II.1.11.2. which was not subject to national restriction measures for animal health reasons, including listed diseases referred to in Annex I to Delegated Regulation (EU) 2020/692 relevant for the species and emerging diseases, at the date of dispatch of the animals to the Union; II.1.11.3. in which at the date of issue of this animal health certificate the following diseases have not been reported for the last 6 months: foot and mouth disease, infection with rinderpest virus, infection with Brucella abortus, B. melitensis and B. suis, infection with Mycobacterium tuberculosis complex (M. bovis, M. caprae, M. tuberculosis), infection with bluetongue virus (serotypes 1-24), [infection with Rift Valley fever virus,] ^{(1) (4)} [infection with Mycoplasma mycoides subsp. mycoides SC (contagious bovine pleuropneumonia),] ^{(1) (5)} [infection with peste des petits ruminants virus,] ^{(1) (6)} [sheep pox and goat pox,] ^{(1) (7)} [contagious caprine pleuropneumonia,] ^{(1) (8)} [infection with lumpy skin disease virus,] ^{(1) (9)} [infection with Burkholderia mallei (glanders),] ^{(1) (10)} [rabies] ^{(1) (11)}; II.1.11.4. in which at the date of issue of this animal health certificate surra (Trypanosoma evansi) and anthrax have not been reported for the last [30 days] ^{(1) (12)} [180 days] ^{(1) (13)}; II.1.11.5. around which, in an area of 10 km radius, including where appropriate the territory of a neighbouring country, none of the following listed diseases has been reported for at least 30 days prior to the date of dispatch of the animals to the Union: foot and mouth disease, infection with rinderpest virus, [infection with Mycoplasma mycoides subsp. mycoides SC (contagious bovine pleuropneumonia),] ^{(1) (5)} [infection with peste des petits ruminants virus,] ^{(1) (6)} [sheep pox and goat pox,] ^{(1) (7)} [contagious caprine pleuropneumonia,] ^{(1) (8)} [infection with Burkholderia mallei (glanders),] ^{(1) (10)} [rabies] ^{(1) (11)}; II.1.11.6. around which, in an area of 150 km radius, including where appropriate the territory of a neighbouring country, none of the following listed diseases has been reported for at least 30 days prior to the date of dispatch of the animals to the Union: infection with bluetongue virus (serotypes 1-24), infection with epizootic haemorrhagic disease virus,[infection with Rift Valley fever virus,] ^{(1) (4)} [infection with lumpy skin disease virus,] ^{(1) (9)}; ⁽¹⁾ either [II.1.12. come from a zone in which at the date of issue of this animal health certificate foot and mouth disease has not been reported for the last 12 months;] ⁽¹⁾ or [II.1.12. have been subjected to a virological and a serological test for evidence of foot and mouth disease virus infection carried out in accordance with one of the prescribed tests for international trade laid down in the World Organisation for Animal Health (WOAH) Manual of Diagnostic Tests and Vaccines for Terrestrial Animals (WOAH Terrestrial Manual), with negative results, on samples taken within the last 10 days prior to the date of dispatch of the animals to the Union;] ⁽¹⁾ either [II.1.13. come from a zone in which at the date of issue of this animal health certificate infection with Rift Valley fever virus has not been reported for the last 48 months;] ⁽¹⁾ or [II.1.13. have: (a) been kept in quarantine in a vector-protected facility in the confined establishment for at least 30 days prior to the date of their dispatch to the Union; (b) showed no disease symptoms of infection with Rift Valley fever virus for at least 30 days prior to the date of their dispatch to the Union; (c) been protected from vectors when transported between the vector-protected facility referred to in point (a) and the place of their loading for dispatch to the Union; (d) undergone a virus neutralisation test with negative results for evidence of infection with Rift Valley fever virus in accordance with the WOAH Terrestrial Manual, carried out firstly on samples taken at the date of commencement of the quarantine period and secondly on samples taken at least 42 days from that date and during the last 10 days prior to the date of their dispatch to the Union;] ⁽¹⁾ either [II.1.14. have not been vaccinated against infection with Brucella abortus, B. melitensis and B. suis and come from a zone in which at the date of issue of this animal health certificate this disease has not been reported for the last 12 months;] ⁽¹⁾ or [II.1.14. have undergone a test as laid down and prescribed for international trade by the WOAH Terrestrial Manual, on samples taken during the last 30 days prior to the date of dispatch of the animals to the Union;] ⁽¹⁾ or [II.1.14. are castrated males of any age;] ⁽¹⁾ either [II.1.15. come from a zone in which at the date of issue of this animal health certificate infection with bluetongue virus (serotypes 1-24) has not been reported for the last 24 months;] ⁽¹⁾ or [II.1.15. have been kept in quarantine in a vector-protected facility in the confined establishment for at least 30 days prior to the date of their dispatch to the Union and have undergone a serology test for infection with bluetongue virus (1-24) and infection with epizootic haemorrhagic disease virus carried out in accordance with the WOAH Terrestrial Manual with negative results, carried out at least 28 days after the date of introduction of the animals into the confined establishment;] ⁽¹⁾ or [II.1.15. have been kept in quarantine in a vector-protected facility in the confined establishment for at least 30 days prior to the date of their dispatch to the Union and have undergone a PCR test for infection with bluetongue virus (1-24) and infection with epizootic haemorrhagic disease virus in accordance with the WOAH Terrestrial Manual, with negative results, carried out at least 14 days after the date of introduction into the confined establishment;] ⁽¹⁾ or [II.1.15. come from a seasonally free zone and have undergone during the free season a serology test for infection with bluetongue virus (1-24) and infection with epizootic haemorrhagic disease virus according to the WOAH Terrestrial Manual, with negative results, carried out on samples taken at least 28 days after the date of introduction of the animals into the confined establishment;] ⁽¹⁾ or [II.1.15. come from a seasonally free zone and have undergone during the free season a PCR test for infection with bluetongue virus (1-24) and infection with epizootic haemorrhagic disease virus in accordance with the WOAH Terrestrial Manual, with negative results, carried out on samples taken at least 14 days after the date of introduction of the animals into the confined establishment;] II.1.16. have been treated at least twice during the last 40 days prior to the date of their dispatch to the Union against internal and external parasites with the following product(s): … … . Specify the active ingredients and the doses of the products used … . Notes: This animal health certificate is intended for the entry into the Union of animals from third countries listed in Part 1 of Annex III to Implementing Regulation (EU) 2021/404 that are originating from and intended for a confined establishment. In accordance with the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union and the European Atomic Energy Community, and in particular Article 5(4) of the Windsor Framework (see Joint Declaration No 1/2023 of the Union and the United Kingdom in the Joint Committee established by the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union and the European Atomic Energy Community of 24 March 2023, OJ L 102, 17.4.2023, p. 87) in conjunction with Annex 2 to that Framework, references to the Union in this animal health certificate include the United Kingdom in respect of Northern Ireland. This animal health certificate shall be completed in accordance with the notes for the completion of certificates provided for in Chapter 4 of Annex I to Commission Implementing Regulation (EU) 2020/2235. Part I: Box reference I.27 : “Identification system and identification number”: Specify the means of identification and the individual identification codes of the animals in accordance with Article 21(1) or Article 21(3) of Delegated Regulation (EU) 2020/692, or, for the zones with an entry “ID” in column 6 of the table in Part 1 of Annex II to Implementing Regulation (EU) 2021/404, in accordance with Article 21(5) of Delegated Regulation (EU) 2020/692. Part II: ⁽¹⁾ Delete if not applicable. ⁽²⁾ Code of the zone as it appears in column 2 of the table in Part 1 of Annex III to Implementing Regulation (EU) 2021/404. ⁽³⁾ Date of loading shall not be prior to the date of authorisation of the zone referred to in point II.1.1 for the entry into the Union, or in a period where restriction measures have been adopted by the Union against entry into the Union of those animals from that zone. ⁽⁴⁾ Not applicable to animals of the family Tragulidae. ⁽⁵⁾ Only applicable to bovine animals and Syncerus caffer. ⁽⁶⁾ Only applicable to ovine animals, caprine animals, camelid animals and cervid animals. ⁽⁷⁾ Only applicable to ovine and caprine animals. ⁽⁸⁾ Only applicable to caprine animals and Gazella spp. ⁽⁹⁾ Only applicable to bovine animals. ⁽¹⁰⁾ Only applicable to caprine animals and camelid animals. ⁽¹¹⁾ Only applicable to animals of the family Bovidae, camelid animals and cervid animals. ⁽¹²⁾ Not applicable to camelid animals. ⁽¹³⁾ Only applicable to camelid animals.

I, the undersigned official veterinarian, hereby certify, that the animals described in Part I: II.1.1. come from the zone with code - ⁽²⁾ which, at the date of issue of this animal health certificate is authorised for the entry into the Union of animals of the families Antilocapridae, Bovidae, Camelidae, Cervidae, Giraffidae, Moschidae, Tragulidae intended for confined establishments and listed in Part 1 of Annex III to Commission Implementing Regulation (EU) 2021/404; II.1.2. have remained continuously in the establishment of origin since birth, or for the last 6 months prior to the date of their dispatch to the Union; II.1.3. have not been in contact with animals of a lower health status for the last 30 days prior to the date of their dispatch to the Union, or since birth, if the animals are less than 30 days of age, and during their transport from the confined establishment of origin to the place of their dispatch to the Union; II.1.4. are not to be killed under a national programme for the eradication of diseases, including the listed diseases referred to in Annex I to Commission Delegated Regulation (EU) 2020/692 relevant for the species and emerging diseases; II.1.5. have been dispatched to the Union directly from the establishment of origin without passing through any other establishment; II.1.6. have not been unloaded in any place that does not comply with the requirements laid down in point II.1.11 since the date of dispatch from their establishment of origin until the date of their dispatch to the Union and during that period they have not been in contact with animals of a lower health status; II.1.7. are loaded for dispatch to the Union on //_ (dd/mm/yyyy) ⁽³⁾ in a means of transport which was cleaned and disinfected prior to loading with a disinfectant authorised by the competent authority in the third country or territory and constructed in such a way that: (a) animals cannot escape or fall out; (b) visual inspection of the space where animals are kept is possible; (c) the escape of animal excrements, litter or feed is prevented or minimized; II.1.8. have been subjected to a clinical inspection within the last 24 hours prior to the time of loading for their dispatch to the Union, carried out by an official veterinarian in the third country or territory of origin, or zone thereof, who did not detect signs indicative of the occurrence of diseases, including the listed diseases referred to in Annex I to Delegated Regulation (EU) 2020/692 relevant for the species and emerging diseases; II.1.9. have not been vaccinated against foot and mouth disease and infection with rinderpest virus; ⁽¹⁾ [II.1.10. have been vaccinated against ⁽¹⁾ [anthrax on //_ (dd/mm/yyyy) with the following vaccine(s): … … (name of vaccine(s) used);]] ⁽¹⁾ [rabies on //____ (dd/mm/yyyy) with the following vaccine(s): … … (name of vaccine(s) used);]] II.1.11. come from a confined establishment: II.1.11.1. which is approved by the competent authority in accordance with the conditions set out in Article 30 of Delegated Regulation (EU) 2020/692; II.1.11.2. which was not subject to national restriction measures for animal health reasons, including listed diseases referred to in Annex I to Delegated Regulation (EU) 2020/692 relevant for the species and emerging diseases, at the date of dispatch of the animals to the Union; II.1.11.3. in which at the date of issue of this animal health certificate the following diseases have not been reported for the last 6 months: foot and mouth disease, infection with rinderpest virus, infection with Brucella abortus, B. melitensis and B. suis, infection with Mycobacterium tuberculosis complex (M. bovis, M. caprae, M. tuberculosis), infection with bluetongue virus (serotypes 1-24), [infection with Rift Valley fever virus,] ^{(1) (4)} [infection with Mycoplasma mycoides subsp. mycoides SC (contagious bovine pleuropneumonia),] ^{(1) (5)} [infection with peste des petits ruminants virus,] ^{(1) (6)} [sheep pox and goat pox,] ^{(1) (7)} [contagious caprine pleuropneumonia,] ^{(1) (8)} [infection with lumpy skin disease virus,] ^{(1) (9)} [infection with Burkholderia mallei (glanders),] ^{(1) (10)} [rabies] ^{(1) (11)}; II.1.11.4. in which at the date of issue of this animal health certificate surra (Trypanosoma evansi) and anthrax have not been reported for the last [30 days] ^{(1) (12)} [180 days] ^{(1) (13)}; II.1.11.5. around which, in an area of 10 km radius, including where appropriate the territory of a neighbouring country, none of the following listed diseases has been reported for at least 30 days prior to the date of dispatch of the animals to the Union: foot and mouth disease, infection with rinderpest virus, [infection with Mycoplasma mycoides subsp. mycoides SC (contagious bovine pleuropneumonia),] ^{(1) (5)} [infection with peste des petits ruminants virus,] ^{(1) (6)} [sheep pox and goat pox,] ^{(1) (7)} [contagious caprine pleuropneumonia,] ^{(1) (8)} [infection with Burkholderia mallei (glanders),] ^{(1) (10)} [rabies] ^{(1) (11)}; II.1.11.6. around which, in an area of 150 km radius, including where appropriate the territory of a neighbouring country, none of the following listed diseases has been reported for at least 30 days prior to the date of dispatch of the animals to the Union: infection with bluetongue virus (serotypes 1-24), infection with epizootic haemorrhagic disease virus,[infection with Rift Valley fever virus,] ^{(1) (4)} [infection with lumpy skin disease virus,] ^{(1) (9)}; ⁽¹⁾ either [II.1.12. come from a zone in which at the date of issue of this animal health certificate foot and mouth disease has not been reported for the last 12 months;] ⁽¹⁾ or [II.1.12. have been subjected to a virological and a serological test for evidence of foot and mouth disease virus infection carried out in accordance with one of the prescribed tests for international trade laid down in the World Organisation for Animal Health (WOAH) Manual of Diagnostic Tests and Vaccines for Terrestrial Animals (WOAH Terrestrial Manual), with negative results, on samples taken within the last 10 days prior to the date of dispatch of the animals to the Union;] ⁽¹⁾ either [II.1.13. come from a zone in which at the date of issue of this animal health certificate infection with Rift Valley fever virus has not been reported for the last 48 months;] ⁽¹⁾ or [II.1.13. have: (a) been kept in quarantine in a vector-protected facility in the confined establishment for at least 30 days prior to the date of their dispatch to the Union; (b) showed no disease symptoms of infection with Rift Valley fever virus for at least 30 days prior to the date of their dispatch to the Union; (c) been protected from vectors when transported between the vector-protected facility referred to in point (a) and the place of their loading for dispatch to the Union; (d) undergone a virus neutralisation test with negative results for evidence of infection with Rift Valley fever virus in accordance with the WOAH Terrestrial Manual, carried out firstly on samples taken at the date of commencement of the quarantine period and secondly on samples taken at least 42 days from that date and during the last 10 days prior to the date of their dispatch to the Union;] ⁽¹⁾ either [II.1.14. have not been vaccinated against infection with Brucella abortus, B. melitensis and B. suis and come from a zone in which at the date of issue of this animal health certificate this disease has not been reported for the last 12 months;] ⁽¹⁾ or [II.1.14. have undergone a test as laid down and prescribed for international trade by the WOAH Terrestrial Manual, on samples taken during the last 30 days prior to the date of dispatch of the animals to the Union;] ⁽¹⁾ or [II.1.14. are castrated males of any age;] ⁽¹⁾ either [II.1.15. come from a zone in which at the date of issue of this animal health certificate infection with bluetongue virus (serotypes 1-24) has not been reported for the last 24 months;] ⁽¹⁾ or [II.1.15. have been kept in quarantine in a vector-protected facility in the confined establishment for at least 30 days prior to the date of their dispatch to the Union and have undergone a serology test for infection with bluetongue virus (1-24) and infection with epizootic haemorrhagic disease virus carried out in accordance with the WOAH Terrestrial Manual with negative results, carried out at least 28 days after the date of introduction of the animals into the confined establishment;] ⁽¹⁾ or [II.1.15. have been kept in quarantine in a vector-protected facility in the confined establishment for at least 30 days prior to the date of their dispatch to the Union and have undergone a PCR test for infection with bluetongue virus (1-24) and infection with epizootic haemorrhagic disease virus in accordance with the WOAH Terrestrial Manual, with negative results, carried out at least 14 days after the date of introduction into the confined establishment;] ⁽¹⁾ or [II.1.15. come from a seasonally free zone and have undergone during the free season a serology test for infection with bluetongue virus (1-24) and infection with epizootic haemorrhagic disease virus according to the WOAH Terrestrial Manual, with negative results, carried out on samples taken at least 28 days after the date of introduction of the animals into the confined establishment;] ⁽¹⁾ or [II.1.15. come from a seasonally free zone and have undergone during the free season a PCR test for infection with bluetongue virus (1-24) and infection with epizootic haemorrhagic disease virus in accordance with the WOAH Terrestrial Manual, with negative results, carried out on samples taken at least 14 days after the date of introduction of the animals into the confined establishment;] II.1.16. have been treated at least twice during the last 40 days prior to the date of their dispatch to the Union against internal and external parasites with the following product(s): … … . Specify the active ingredients and the doses of the products used … . Notes: This animal health certificate is intended for the entry into the Union of animals from third countries listed in Part 1 of Annex III to Implementing Regulation (EU) 2021/404 that are originating from and intended for a confined establishment. In accordance with the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union and the European Atomic Energy Community, and in particular Article 5(4) of the Windsor Framework (see Joint Declaration No 1/2023 of the Union and the United Kingdom in the Joint Committee established by the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union and the European Atomic Energy Community of 24 March 2023, OJ L 102, 17.4.2023, p. 87) in conjunction with Annex 2 to that Framework, references to the Union in this animal health certificate include the United Kingdom in respect of Northern Ireland. This animal health certificate shall be completed in accordance with the notes for the completion of certificates provided for in Chapter 4 of Annex I to Commission Implementing Regulation (EU) 2020/2235. Part I: Box reference I.27 : “Identification system and identification number”: Specify the means of identification and the individual identification codes of the animals in accordance with Article 21(1) or Article 21(3) of Delegated Regulation (EU) 2020/692, or, for the zones with an entry “ID” in column 6 of the table in Part 1 of Annex II to Implementing Regulation (EU) 2021/404, in accordance with Article 21(5) of Delegated Regulation (EU) 2020/692. Part II: ⁽¹⁾ Delete if not applicable. ⁽²⁾ Code of the zone as it appears in column 2 of the table in Part 1 of Annex III to Implementing Regulation (EU) 2021/404. ⁽³⁾ Date of loading shall not be prior to the date of authorisation of the zone referred to in point II.1.1 for the entry into the Union, or in a period where restriction measures have been adopted by the Union against entry into the Union of those animals from that zone. ⁽⁴⁾ Not applicable to animals of the family Tragulidae. ⁽⁵⁾ Only applicable to bovine animals and Syncerus caffer. ⁽⁶⁾ Only applicable to ovine animals, caprine animals, camelid animals and cervid animals. ⁽⁷⁾ Only applicable to ovine and caprine animals. ⁽⁸⁾ Only applicable to caprine animals and Gazella spp. ⁽⁹⁾ Only applicable to bovine animals. ⁽¹⁰⁾ Only applicable to caprine animals and camelid animals. ⁽¹¹⁾ Only applicable to animals of the family Bovidae, camelid animals and cervid animals. ⁽¹²⁾ Not applicable to camelid animals. ⁽¹³⁾ Only applicable to camelid animals.


Official veterinarian	Official veterinarian
Name (in capital letters)
Date	Qualification and title
Stamp	Signature

CHAPTER 19 (MODEL “CONFINED-SUI”)

Section 1

List of animals originating from and intended for a confined establishment covered by the model “CONFINED-SUI” set out in Section 2

Order	Family	Genera/species
Artiodactyla	Suidae	Babyrousa ssp., Hylochoerus ssp., Phacochoerus ssp., Potamochoerus ssp., Sus ssp.
Artiodactyla	Tayassuidae	Catagonus ssp., Pecari-Tayassu ssp.

Section 2 MODEL ANIMAL HEALTH CERTIFICATE FOR THE ENTRY INTO THE UNION OF ANIMALS LISTED IN CHAPTER 19, SECTION 1, OF ANNEX II TO COMMISSION IMPLEMENTING REGULATION (EU) 2021/403 THAT ARE ORIGINATING FROM AND INTENDED FOR A CONFINED ESTABLISHMENT (MODEL “CONFINED-SUI”)

Part I: Description of consignment


COUNTRY	Animal health certificate to the EU

---	---
I.1	Consignor/Exporter
	Name
	Address
	Address
	Country
I.5	Consignee/Importer
	Name
	Address
	Country
I.7	Country of origin
I.8	Region of origin
I.11	Place of dispatch
	Name
	Address
	Country
I.13	Place of loading

---	---
I.15	Means of transport
	☐ Aircraft
	☐ Railway
	Identification
	Identification

---	---
I.18
I.19	Container number/Seal number
	Container No
I.20	Certified as or for


---	---
I.21


---	---
I.24

---	---
I.27	Description of consignment
CN code	Species

Part II: Certification


COUNTRY	COUNTRY	Certificate model CONFINED-SUI	Certificate model CONFINED-SUI	Certificate model CONFINED-SUI	Certificate model CONFINED-SUI
	II. Health information	II.a	Certificate reference	II.b	IMSOC reference


I, the undersigned official veterinarian, hereby certify, that the animals described in Part I: II.1.1. come from the zone with code - ⁽²⁾ which, at the date of issue of this animal health certificate is authorised for the entry into the Union of animals of the families Suidae and Tayassuidae intended for confined establishments and listed in Part 1 of Annex III to Commission Implementing Regulation (EU) 2021/404; II.1.2. have remained continuously in the establishment of origin since birth or for at least 6 months prior to the date of their dispatch to the Union; II.1.3. have not been in contact with animals of a lower health status for the last 30 days prior to the date of their dispatch to the Union, or since birth, if the animals are less than 30 days of age, and during their transport from the confined establishment of origin to the place of their dispatch to the Union; II.1.4. are not to be killed under a national programme for the eradication of diseases, including the listed diseases referred to in Annex I to Commission Delegated Regulation (EU) 2020/692 relevant for the species and emerging diseases; II.1.5. have been dispatched to the Union directly from the establishment of origin without passing through any other establishment; II.1.6. have not been unloaded in any place that does not comply with the requirements laid down in point II.1.11 since the date of dispatch from their establishment of origin until the date of their dispatch to the Union and during that period they have not been in contact with animals of a lower health status; II.1.7. are loaded for dispatch to the Union on //_ (dd/mm/yyyy) ⁽³⁾ in a means of transport which was cleaned and disinfected prior to loading with a disinfectant authorised by the competent authority in the third country or territory and constructed in such a way that: (a) animals cannot escape or fall out; (b) visual inspection of the space where animals are kept is possible; (c) the escape of animal excrements, litter or feed is prevented or minimized; II.1.8. have been subjected to a clinical inspection within the last 24 hours prior to the time of their loading for dispatch to the Union, carried out by an official veterinarian in the third country or territory of origin, or zone thereof, who did not detect signs indicative of the occurrence of diseases, including the listed diseases referred to in Annex I to Delegated Regulation (EU) 2020/692 relevant for the species and emerging diseases; II.1.9. have not been vaccinated against foot and mouth disease and infection with rinderpest virus; ⁽¹⁾ [II.1.10. have been vaccinated against ⁽¹⁾ [anthrax on //_ (dd/mm/yyyy) with the following vaccine(s): … … (name of vaccine(s) used);] ⁽¹⁾ [rabies on //____ (dd/mm/yyyy) with the following vaccine(s): … … (name of vaccine(s) used);]] II.1.11. come from a confined establishment: II.1.11.1. which is approved by the competent authority in accordance with the conditions set out in Article 30 of Delegated Regulation (EU) 2020/692; II.1.11.2. which was not subject to national restriction measures for animal health reasons, including listed diseases referred to in Annex I to Delegated Regulation (EU) 2020/692 relevant for the species and emerging diseases, at the date of dispatch of the animals to the Union; II.1.11.3. in which at the date of issue of this animal health certificate the following diseases have not been reported for the last 6 months: foot and mouth disease, infection with rinderpest virus, classical swine fever, infection with Brucella abortus, B. melitensis and B. suis, rabies [, African swine fever] ^{(1) (4)}; II.1.11.4. in which at the date of issue of this animal health certificate surra (Trypanosoma evansi) and anthrax have not been reported for the last 30 days; II.1.11.5. around which, in an area of 10 km radius, including where appropriate the territory of a neighbouring country, none of the following listed diseases has been reported for the last 12 months prior to the date of dispatch of the animals to the Union: foot and mouth disease, infection with rinderpest virus, classical swine fever, rabies [, African swine fever] ^{(1) (4)}; ⁽¹⁾ either [II.1.12. come from a zone in which at the date of issue of this animal health certificate foot and mouth disease has not been reported for the last 12 months;] ⁽¹⁾ or [II.1.12. have been subjected to a virological and a serological test for evidence of foot and mouth disease virus infection carried out in accordance with one of the prescribed tests for international trade laid down in the WOAH Manual of Diagnostic Tests and Vaccines for Terrestrial Animals (WOAH Terrestrial Manual), with negative results, on samples taken within the last 10 days prior to the date of dispatch of the animals to the Union;] ⁽¹⁾ either [II.1.13. come from a zone in which at the date of issue of this animal health certificate classical swine fever has not been reported for the last 12 months;] ⁽¹⁾ or [II.1.13. have undergone a virology and serology test for the detection of classical swine fever in accordance with the test prescribed for international trade in the WOAH Terrestrial Manual, carried out on samples taken during the last 30 days prior to the date of dispatch of the animals to the Union;] ^{(1) (4)} [⁽¹⁾ either [II.1.14. come from a zone in which at the date of issue of this animal health certificate African swine fever has not been reported for the last 12 months;]] ⁽¹⁾ or [II.1.14. have undergone a virology and serology test for the detection of African swine fever and in accordance with the test prescribed for international trade in the WOAH Terrestrial Manual, carried out on samples taken during the last 30 days prior to the date of dispatch of the animals to the Union;]] ⁽¹⁾ either [II.1.15. have not been vaccinated against infection with Brucella abortus, B. melitensis and B. suis and come from a zone in which at the date of issue of this animal health certificate this disease has not been reported for the last 12 months;] ⁽¹⁾ or [II.1.15. have undergone a test as laid down and prescribed for international trade by the WOAH Terrestrial Manual, on samples taken during the last 30 days prior to the date of dispatch of the animals to the Union;] ⁽¹⁾ or [II.1.15. are castrated males of any age;] II.1.16. have been treated at least twice during the last 40 days prior to the date of dispatch of the animals to the Union against internal and external parasites with the following product(s): … . Specify the active ingredients and the doses of the products used … . Notes: This animal health certificate is intended for the entry into the Union of animals from third countries listed in Part 1 of Annex III to Commission Implementing Regulation (EU) 2021/404 that are originating from and intended for a confined establishment. In accordance with the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union and the European Atomic Energy Community, and in particular Article 5(4) of the Windsor Framework (see Joint Declaration No 1/2023 of the Union and the United Kingdom in the Joint Committee established by the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union and the European Atomic Energy Community of 24 March 2023, OJ L 102, 17.4.2023, p. 87) in conjunction with Annex 2 to that Framework, references to the Union in this animal health certificate include the United Kingdom in respect of Northern Ireland. This animal health certificate shall be completed in accordance with the notes for the completion of certificates provided for in Chapter 4 of Annex I to Commission Implementing Regulation (EU) 2020/2235. Part I: Box reference I.27 : “Identification system and identification number”: Specify the means of identification and the individual identification codes of the animals in accordance with Article 21(1) or (3) of Delegated Regulation (EU) 2020/692; or, for the zones with an entry “ID” in column 6 of the table in Part 1 of Annex II to Implementing Regulation (EU) 2021/404, in accordance with Article 21(5) of Delegated Regulation (EU) 2020/692. Part II: ⁽¹⁾ Delete if not applicable. ⁽²⁾ Code of the zone as it appears in column 2 of the table in Part 1 of Annex III to Implementing Regulation (EU) 2021/404. ⁽³⁾ Date of loading shall not be prior to the date of authorisation of the zone referred to in point II.1.1 for the entry into the Union, or in a period where restriction measures have been adopted by the Union against entry into the Union of those animals from that zone. ⁽⁴⁾ Not applicable to animals of the family Tayassuidae.


Official veterinarian	Official veterinarian
Name (in capital letters)
Date	Qualification and title
Stamp	Signature

CHAPTER 20 (MODEL “CONFINED-TRE”)

Section 1

List of animals originating from and intended for a confined establishment covered by model “CONFINED-TRE” set out in Section 2

Order	Family	Genera/species
Perissodactyla	Tapiridae	Tapirus ssp.
Perissodactyla	Rhinocerotidae	Ceratotherium ssp., Dicerorhinus ssp., Diceros ssp., Rhinoceros ssp.
Proboscidea	Elephantidae	Elephas ssp., Loxodonta ssp.

Section 2 MODEL ANIMAL HEALTH CERTIFICATE FOR THE ENTRY INTO THE UNION OF ANIMALS LISTED IN CHAPTER 20, SECTION 1, OF ANNEX II TO COMMISSION IMPLEMENTING REGULATION (EU) 2021/403 THAT ARE ORIGINATING FROM AND INTENDED FOR A CONFINED ESTABLISHMENT (MODEL “CONFINED-TRE”)

Part I: Description of consignment


COUNTRY	Animal health certificate to the EU

---	---
I.1	Consignor/Exporter
	Name
	Address
	Address
	Country
I.5	Consignee/Importer
	Name
	Address
	Country
I.7	Country of origin
I.8	Region of origin
I.11	Place of dispatch
	Name
	Address
	Country
I.13	Place of loading

---	---
I.15	Means of transport
	☐ Aircraft
	☐ Railway
	Identification
	Identification

---	---
I.18
I.19	Container number/Seal number
	Container No
I.20	Certified as or for


---	---
I.21


---	---
I.24

---	---
I.27	Description of consignment
CN code	Species

Part II: Certification


COUNTRY	COUNTRY	Certificate model CONFINED-TRE	Certificate model CONFINED-TRE	Certificate model CONFINED-TRE	Certificate model CONFINED-TRE
	II. Health information	II.a	Certificate reference	II.b	IMSOC reference


I, the undersigned official veterinarian, hereby certify, that the animals described in Part I: II.1.1. come from the zone with code - ⁽²⁾ which, at the date of issue of this animal health certificate is authorised for the entry into the Union of animals of the families Tapiridae, Rhinocerotidae and Elephantidae intended for confined establishments and listed in Part 1 of Annex III to Commission Implementing Regulation (EU) 2021/404; II.1.2. have remained continuously in the establishment of origin since birth, or for at least 6 months prior to the date of their dispatch to the Union; II.1.3. have not been in contact with animals of a lower health status for the last 30 days prior to the date of their dispatch to the Union, or since birth, if the animals are less than 30 days of age, and during their transport from the confined establishment of origin to the place of their dispatch to the Union; II.1.4. are not to be killed under a national programme for the eradication of diseases, including the listed diseases referred to in Annex I to Commission Delegated Regulation (EU) 2020/692 relevant for the species and emerging diseases; II.1.5. have been dispatched to the Union directly from the establishment of origin without passing through any other establishment; II.1.6. have not been unloaded in any place that does not comply with the requirements laid down in point II.1.11 since the date of dispatch from their establishment of origin until the date of their dispatch to the Union and during that period they have not been in contact with animals of a lower health status; II.1.7. are loaded for dispatch to the Union on //_ (dd/mm/yyyy) ⁽³⁾ in a means of transport which was cleaned and disinfected prior to loading with a disinfectant authorised by the competent authority in the third country or territory and constructed in such a way that: (a) animals cannot escape or fall out; (b) visual inspection of the space where animals are kept is possible; (c) the escape of animal excrements, litter or feed is prevented or minimized; II.1.8. have been subjected to a clinical inspection within the last 24 hours prior to the time of loading for dispatch to the Union, carried out by an official veterinarian in the third country or territory of origin, or zone thereof, who did not detect signs indicative of the occurrence of diseases, including the listed diseases referred to in Annex I to Delegated Regulation (EU) 2020/692 relevant for the species and emerging diseases; II.1.9. have not been vaccinated against foot and mouth disease and infection with rinderpest virus; ⁽¹⁾ [II.1.10. have been vaccinated against ⁽¹⁾ [anthrax on //_ (dd/mm/yyyy) with the following vaccine(s): … … (name of vaccine(s) used);]] ⁽¹⁾ [rabies on //____ (dd/mm/yyyy) with the following vaccine(s) … … (name of vaccine(s) used);]] II.1.11. come from a confined establishment: II.1.11.1. which is approved by the competent authority in accordance with the conditions set out in Article 30 of Delegated Regulation (EU) 2020/692; II.1.11.2. which was not subject to national restriction measures for animal health reasons, including listed diseases referred to in Annex I to Delegated Regulation (EU) 2020/692 relevant for the species and emerging diseases, at the date of dispatch of the animals to the Union; II.1.11.3. in which at the date of issue of this animal health certificate the following diseases have not been reported for the last 6 months: infection with rinderpest virus, infection with Rift Valley fever virus [, foot and mouth disease] ^{(1) (4)}; II.1.11.4. in which at the date of issue of this animal health certificate anthrax has not been reported for the last 30 days; ^{(1) (4)} [II.1.11.5. around which, in an area of 10 km radius, including where appropriate the territory of a neighbouring country, foot and mouth disease has not been reported for the last 30 days prior to the date of dispatch of the animals to the Union;] II.1.11.6. around which, in an area of 150 km radius, including where appropriate the territory of a neighbouring country, infection with Rift Valley fever virus has not been reported for the last 30 days prior to the date of dispatch of the animals to the Union; ^{(1) (4)} [⁽¹⁾ either [II.1.12. come from a zone in which at the date of issue of this animal health certificate foot and mouth disease has not been reported for the last 12 months;]] ⁽¹⁾ or [II.1.12. have been subjected to a virological and a serological test for evidence of foot and mouth disease virus infection carried out in accordance with one of the prescribed tests for international trade laid down in the WOAH Manual of Diagnostic Tests and Vaccines for Terrestrial Animals (WOAH Terrestrial Manual), with negative results, on samples taken within the last 10 days prior to the date of dispatch of the animals to the Union;]] ⁽¹⁾ either [II.1.13. come from a zone in which at the date of issue of this animal health certificate infection with Rift Valley fever virus has not been reported for the last 48 months;] ⁽¹⁾ or [II.1.13. have: (a) been kept in quarantine in a vector-protected facility in the confined establishment for at least 30 days prior to the date of dispatch of the animals to the Union; (b) showed no disease symptoms of infection with Rift Valley fever virus for at least 30 days prior to the date of dispatch of the animals to the Union; (c) been protected from vectors when transported between the vector-protected facility referred to in point (a) and the place of loading for their dispatch to the Union; (d) undergone a virus neutralisation test with negative results for evidence of infection with Rift Valley fever virus in accordance with the WOAH Terrestrial Manual, carried out firstly on samples taken at the date of commencement of the quarantine period and secondly on samples taken at least 42 days from that date and during the last 10 days prior to the date of their dispatch to the Union; II.1.14. have been treated at least twice during the last 40 days prior to the date of their dispatch to the Union against internal and external parasites with the following product(s): … … . Specify the active ingredients and the doses of the products used … . Notes: This animal health certificate is intended for the entry into the Union of animals from third countries listed in Part 1 of Annex III to Implementing Regulation (EU) 2021/404 that are originating from and intended for a confined establishment. In accordance with the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union and the European Atomic Energy Community, and in particular Article 5(4) of the Windsor Framework (see Joint Declaration No 1/2023 of the Union and the United Kingdom in the Joint Committee established by the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union and the European Atomic Energy Community of 24 March 2023, OJ L 102, 17.4.2023, p. 87) in conjunction with Annex 2 to that Framework, references to the Union in this animal health certificate include the United Kingdom in respect of Northern Ireland. This animal health certificate shall be completed in accordance with the notes for the completion of certificates provided for in Chapter 4 of Annex I to Commission Implementing Regulation (EU) 2020/2235. Part I: Box reference I.27 : “Identification system and identification number”: Specify the means of identification and the individual identification codes of the animals in accordance with Article 21(1) or Article 21(3) of Delegated Regulation (EU) 2020/692; or, for the zones with an entry “ID” in column 6 of the table in Part 1 of Annex II to Implementing Regulation (EU) 2021/404, in accordance with Article 21(5) of Delegated Regulation (EU) 2020/692. Part II: ⁽¹⁾ Delete if not applicable. ⁽²⁾ Code of the zone as it appears in column 2 of the table in Part 1 of Annex III to Implementing Regulation (EU) 2021/404. ⁽³⁾ Date of loading shall not be prior to the date of authorisation of the zone referred to in point II.1.1 for the entry into the Union, or in a period where restriction measures have been adopted by the Union against entry into the Union of those animals from that zone. ⁽⁴⁾ Only applicable to animals of the family Elephantidae.


Official veterinarian	Official veterinarian
Name (in capital letters)
Date	Qualification and title
Stamp	Signature

CHAPTER 21 MODEL ANIMAL HEALTH CERTIFICATE FOR THE ENTRY INTO THE UNION OF ANIMALS OF THE FAMILY OF HIPPOPOTAMIDAE THAT ARE ORIGINATING FROM AND INTENDED FOR A CONFINED ESTABLISHMENT (MODEL “CONFINED-HIPPO”)

Part I: Description of consignment

Reading this document does not replace reading the official text published in the Official Journal of the European Union. We assume no responsibility for any inaccuracies arising from the conversion of the original to this format.

This text is published under EUR-Lex's own terms of reuse, not a Legalize or public-domain licence. EUR-Lex
Creative Commons Attribution 4.0 International (CC BY 4.0)
© European Union, https://eur-lex.europa.eu — Source: EUR-Lex (Publications Office of the European Union). Reused under the Creative Commons Attribution 4.0 International (CC BY 4.0) licence. Only EU legislation published in the printed Official Journal of the European Union is deemed authentic; consolidated texts are reproduced here for documentation purposes and have been reformatted to Markdown.